Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26F9BL9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,931
Award facts
- Contract value 100% obligated
- $41,930.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $41,930.85 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Imfinzi 500 mg/10 mL vials. This firm fixed-price contract, with an ultimate completion date of December 5, 2025, represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Imfinzi (durvalumab) is an immunotherapy medication used in oncology treatment, underscoring DLA's role in procuring specialized pharmaceutical products for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 pharmaceutical supply vehicle running through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen leverages this prime contract to supply medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The company's selection reflects its proven capability to meet federal procurement requirements and deliver critical pharmaceutical products to military and veteran healthcare networks.
Quick answers
Who was awarded contract SPE2DR26F9BL9?
SPE2DR26F9BL9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F9BL9 worth?
The government has obligated $41,931 on SPE2DR26F9BL9.
Is contract SPE2DR26F9BL9 an order under another contract?
Yes. SPE2DR26F9BL9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BL9 competed?
The extent of competition for SPE2DR26F9BL9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award